Prof. Akiko Iwasaki
@VirusesImmunity
We study antiviral immunity and viral disease pathogenesis. #COVID19 #longCOVID #vaccines @HHMINEWS @YaleIBIO @YaleMed @YaleCII
To all aspiring young #WomenInSTEM: Mentee: Should I avoid being pregnant while trying to secure a faculty position? Me: Be pregnant & go on interviews. If they don’t welcome you with open arms and offer childcare options, they don’t deserve you. #KnowYourWorth
New preprint led by @JennyLund15: analysis of 232 participants shows that during HSV-2 shedding, T cells and dendritic cells form clusters in the cervicovaginal epithelia — helping maintain viral surveillance and limit damage. #GenitalHerpes #HSV2 biorxiv.org/content/10.110…
V. excited to join the SPEAR (Spike Protein Elimination and Recovery) team with @MichaelPelusoMD @microbeminded2 @PutrinoLab @Invivyd to study whether broadly neutralizing mAb can treat Long COVID and post-vaccination syndrome subset driven by persistent spike protein.…
Yale immunologist Dr. Akiko Iwasaki to probe monoclonal antibodies for Long COVID and post-vaccine syndrome, aiming to test if spike protein persistence drives symptoms and if targeted antibodies can offer relief. investors.invivyd.com/news-releases/…
La empresa Invivyd ha anunciado que la profesora de Yale, Akiko Iwasaki, se ha unido a su Grupo de Estudio SPEAR, centrado en la proteína Spike del SARS-CoV-2. La dra es experta en patogenesis viral y en inmunologia humana. @VirusesImmunity @YaleMedicine es.investing.com/news/company-n…
Scientist Dr. Akiko Iwasaki @VirusesImmunity Joins SPEAR Study Group to Investigate Monoclonal Antibodies for Long COVID and COVID-19 Post-Vaccination Syndrome investors.invivyd.com/news-releases/…
Great article on Dr. David Knipe, a virologist at @Harvard who has studied HSV for over four decades. We are so grateful on his continued commitment to studying HSV! #CureHSV #SilentNoMore #HerpesAdvocate magazine.hms.harvard.edu/articles/i-am-…
岩崎先生が、この記事でとりあげられていた論文の解説をしてくださっています。 新型コロナ後遺症の発症メカニズム、一端を解明 米研究チーム mainichi.jp/articles/20250…
A fascinating new study by Vishnu Shankar et al. @stanfordimmuno shows that oxidative stress is a shared characteristic of ME/CFS and Long COVID in lymphocytes due to inability to clear reactive oxygen species. This happens in sex-specific manner. (1/) pnas.org/doi/abs/10.107…
“Neuro-Long COVlD” thru direct infection, viral persistence, neuroinflammation, T-cell infiltration, autoimmunity, impaired neurotransmitter metabolism, vascular complications, tissue hypoxia, & exacerbation of Parkinson’s & Alzheimer’s demands prevention. doi.org/10.1111/pcn.13…
Be part of a 180-day trial testing the effects of Truvada and Miraviroc on chronic symptoms. For more information, email [email protected].
🎆 Every #July4th, we celebrate the exemplary contributions of immigrants to American life. Meet the 2025 #GreatImmigrants — Great Americans who enrich our democracy through their lives, their work, and their examples. 🇺🇸 Learn more: carnegie.io/3TbE2ew
Congratulations @VirusesImmunity, Helen Blou, and many Great Immigrants Great Americans recognized today by @CarnegieCorp #Happy4th
The newly launched (gorgeous) Center for Infectious Diseases Education and Research (CiDER) @cider_pr at Osaka University is seeking a full-time specially appointed associate professor in #InfectiousDiseases. #FacultyPosition 🇯🇵 For more detail👇🏼 dropbox.com/scl/fi/pyocpu7…
BREAKING: Anecdotes are wonderful - let’s go get the data! Invivyd & leading researchers launch SPEAR Study Group to explore effects of mAb therapy on people suffering from Long COVID & post-vaccination syndrome. investors.adagiotx.com/news-releases/… @UCSF @polybioRF @michaelpelusoMD…
This study of Akiko Iwasaki @VirusesImmunity was co-funded by @weandmecfs We need more patient-led research ...
Immune Markers Help Identify Subgroups of #MECFS Patients the-scientist.com/profiling-immu…
Die aktuelle Studie von Akiko Iwasaki @VirusesImmunity belegt klar, dass ME/CFS verschiedene immunologische Subtypen umfasst. Erhöhte MMPs im Liquor könnten auch therapeutisch beeinflussbar und IL-7 dafür ein Marker im Blut sein. the-scientist.com/profiling-immu…
Participate in a trial testing the effectiveness of Truvada and Miraviroc in reducing symptoms of Long COVID. For more information, contact [email protected].